Trade Aytu BioScience, Inc. - AYTU CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.076 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.682 |
| Open | 2.692 |
| 1-Year Change | 62.46% |
| Day's Range | 2.672 - 2.762 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 26, 2024 | 2.682 | -0.010 | -0.37% | 2.692 | 2.762 | 2.622 |
| Jul 25, 2024 | 2.672 | -0.070 | -2.55% | 2.742 | 2.742 | 2.622 |
| Jul 24, 2024 | 2.742 | 0.050 | 1.86% | 2.692 | 2.792 | 2.692 |
| Jul 23, 2024 | 2.762 | 0.020 | 0.73% | 2.742 | 2.782 | 2.682 |
| Jul 22, 2024 | 2.752 | 0.020 | 0.73% | 2.732 | 2.792 | 2.692 |
| Jul 19, 2024 | 2.782 | 0.120 | 4.51% | 2.662 | 2.812 | 2.662 |
| Jul 18, 2024 | 2.782 | 0.050 | 1.83% | 2.732 | 2.832 | 2.662 |
| Jul 17, 2024 | 2.812 | 0.070 | 2.55% | 2.742 | 2.822 | 2.642 |
| Jul 16, 2024 | 2.762 | -0.010 | -0.36% | 2.772 | 2.802 | 2.702 |
| Jul 15, 2024 | 2.812 | 0.150 | 5.63% | 2.662 | 2.812 | 2.662 |
| Jul 12, 2024 | 2.682 | -0.100 | -3.59% | 2.782 | 2.832 | 2.682 |
| Jul 11, 2024 | 2.802 | 0.090 | 3.32% | 2.712 | 2.842 | 2.712 |
| Jul 10, 2024 | 2.772 | 0.010 | 0.36% | 2.762 | 2.872 | 2.702 |
| Jul 9, 2024 | 2.822 | 0.090 | 3.29% | 2.732 | 2.882 | 2.702 |
| Jul 8, 2024 | 2.842 | 0.100 | 3.65% | 2.742 | 2.872 | 2.712 |
| Jul 5, 2024 | 2.802 | 0.070 | 2.56% | 2.732 | 2.872 | 2.732 |
| Jul 3, 2024 | 2.762 | 0.040 | 1.47% | 2.722 | 2.782 | 2.722 |
| Jul 2, 2024 | 2.822 | 0.090 | 3.29% | 2.732 | 2.832 | 2.662 |
| Jul 1, 2024 | 2.812 | 0.080 | 2.93% | 2.732 | 2.852 | 2.652 |
| Jun 28, 2024 | 2.832 | 0.060 | 2.16% | 2.772 | 2.832 | 2.772 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Aytu BioScience, Inc. Company profile
About Aytu Biopharma Inc
Aytu Biopharma, Inc., formerly Aytu BioScience, Inc., is a specialty pharmaceutical company. The Company markets a portfolio of prescription products addressing primary care and pediatric markets. The Company's primary prescription products treat attention deficit hyperactivity disorder (ADHD) and other common pediatric conditions. It markets ADHD products Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets, Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets, and Adzenys-ER (amphetamine) extended-release oral suspension. The Company's other pediatric products include Karbinal ER (carbinoxamine maleate), an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary fluoride-based prescription vitamin product lines containing combinations of fluoride and vitamins in formulations for infants and children with fluoride deficiency.
Financial summary
BRIEF: For the six months ended 31 December 2021, Aytu Biopharma Inc revenues increased 57% to $45M. Net loss increased from $13.8M to $39.4M. Revenues reflect United States segment increase of 69% to $43.7M. Basic Earnings per Share excluding Extraordinary Items decreased from -$1.07 to -$1.53.
Equity composition
Common Stock no Par, 11/11, 30M auth., 4,774,568 issd. Insiders own 66.98%. 06/15, 1-for-12.174, Reverse Stock Split.
| Industry: | Pharmaceuticals (NEC) |
7900 E. Union Avenue
Suite 920
DENVER
COLORADO 80237
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com